NOMINATION RIGHTS AGREEMENTNomination Rights Agreement • February 13th, 2019 • Omega Fund IV, L.P. • Pharmaceutical preparations • British Columbia
WHEREAS the Investor desires to purchase an aggregate of 20,000,000 securities comprised of a combination of Shares and pre-funded common share purchase warrants of the Corporation (the “Investment”) as part of a larger offering of Shares and pre-funded common share purchase warrants of the Corporation by way of a second amended and restated prospectus supplement dated January 5, 2018 to a short form base shelf prospectus dated December 22, 2015.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2019 • Omega Fund IV, L.P. • Pharmaceutical preparations
Joint Filing Agreement, dated as of February 13, 2019, is by and among the various reporting persons that are listed in the signature blocks below (the “Omega Filers”).
